Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of methadone metabolites for treatment of anxiety and depression

Use of methadone metabolites for treatment of anxiety and depression

US Patent 10709685 · Granted Jul 14, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of methadone metabolites for treatment of anxiety and depression2022
Use of methadone metabolites for treatment of anxiety and depression2022
Use of methadone metabolites for treatment of anxiety and depression2022
2-halo-5-alkynyl-pyridyl nicotinic ligands2019
2-halo-5-alkynyl-pyridyl nicotinic ligands2019
2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof2018
2,5-disubstituted-pyridyl nicotinic ligands, and methods of use thereof2018
Phenyl-substituted nicotinic ligands, and methods of use thereof2018
Phenyl-substituted nicotinic ligands, and methods of use thereof2018
2-halo-5-alkynyl-pyridyl nicotinic ligands2018
2-halo-5-alkynyl-pyridyl nicotinic ligands2018
Phenyl-substituted nicotinic ligands, and methods of use thereof2016